Recently, RKIP has been implicated as a metastatic suppressor for prostate cancer and breast cancer [44], [45] while hPEBP4 overexprression positively corelated with the metastasis of lung squamous cell carcinomas and colorectal cancer [14], [18]. Here, PEBP4 is linked to prostate carcinoma.